Weekly, paclitaxel plus carboplatin in patients with metastatic transitional cell carcinoma of the urothelium who failed MVAC: Phase II trial

被引:0
|
作者
Kouno, T. [1 ]
Ando, M. [1 ]
Yonemori, K. [1 ]
Matsumoto, K. [1 ]
Komiyama, M. [1 ]
Okajima, E. [1 ]
Matsuoka, N. [1 ]
Fujimoto, H. [1 ]
Fujiwara, Y. [1 ]
机构
[1] Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
来源
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:246 / 247
页数:2
相关论文
共 50 条
  • [1] Weekly paclitaxel (P) plus carboplatin (C) as salvage therapy in metastatic transitional cell carcinoma (TCC) of the urothelium previously treated with MVAC: Phase II trial.
    Kouno, T
    Ando, M
    Yonemori, K
    Matsumoto, K
    Shimizu, C
    Komiyama, M
    Okajima, E
    Matsuoka, N
    Fujimoto, H
    Fujiwara, Y
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 432S - 432S
  • [2] A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
    Xu, Nong
    Zhang, Xiao Chen
    Xiong, Jian Ping
    Fang, Wei Jia
    Yu, Lan Fang
    Qian, Jiong
    Zhang, Ling
    [J]. BMC CANCER, 2007, 7 (1)
  • [3] A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
    Nong Xu
    Xiao Chen Zhang
    Jian Ping Xiong
    Wei Jia Fang
    Lan Fang Yu
    Jiong Qian
    Ling Zhang
    [J]. BMC Cancer, 7
  • [4] Phase II trial of weekly paclitaxel and carboplatin chemotherapy in patients with advanced transitional cell cancer
    Johannsen, M
    Sachs, M
    Roigas, J
    Hinke, A
    Staack, A
    Loening, SA
    Schnorr, D
    Wille, AH
    [J]. EUROPEAN UROLOGY, 2005, 48 (02) : 246 - 251
  • [5] Phase II study of Taxol (paclitaxel) and Carboplatin in patients with advanced transitional-cell carcinoma of the urothelium (TCC)
    Mottet, N
    Prapotnich, D
    Beuzeboc, P
    Di Palma, M
    Bui, N
    Eymard, JC
    Mercat, A
    Garet, F
    Droz, JP
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 59 - 59
  • [6] Phase II trial of paclitaxel and carboplatin in advanced/metastatic transitional cell cancer
    Wille, AH
    Johannsen, M
    Roigas, J
    Schnorr, DR
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04): : 380 - 381
  • [7] A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium
    von der Maase, H.
    Lehmann, J.
    Gravis, G.
    Joensuu, H.
    Geertsen, P. F.
    Gough, J.
    Chen, G.
    Kania, M.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (10) : 1533 - 1538
  • [8] Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium - A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Meluch, AA
    Litchy, S
    Schnell, FM
    Bearden, JD
    Yost, K
    Greco, FA
    [J]. CANCER, 2005, 103 (11) : 2298 - 2303
  • [9] Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium:: A phase II clinical trial
    von der Maase, H
    Andersen, L
    Crinò, L
    Weinknecht, S
    Dogliotti, L
    [J]. ANNALS OF ONCOLOGY, 1999, 10 (12) : 1461 - 1465
  • [10] Phase II trial of gemcitabine plus carboplatin for urothelial transitional cell carcinoma (UTCC) in advanced or metastatic stage
    Santoro, A
    Santoro, M
    Maiorino, L
    Forestieri, V
    Forestieri, P
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 169 - 169